Search Results - "Dreden, Patrick Van"

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum? by Van Dreden, Patrick, Fareed, Jawed, Elalamy, Ismail, Gerotziafas, Grigoris

Get full text

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study by Van Dreden, Patrick, Lefkou, Eleftheria, Ka, Aboubakar, Sfakianoudis, Konstantinos, Rousseau, Aurélie, Grusse, Matthieu, Elalamy, Ismail, Gerotziafas, Grigoris T

“…Background The ROADMAP-EOP study aimed to identify clinically relevant biomarkers of hypercoagulability for the identification of pregnant women at risk of…”
Get full text

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study by Gerotziafas, Grigoris T., Zografos, Theodoros, Pantos, Ioannis, Lefkou, Eleftheria, Carlo, Audrey, Fareed, Jawed, Van Dreden, Patrick, Katritsis, Demosthenes

“…In patients with stable coronary artery disease (CAD) blood hypercoagulability figures among factors leading to thrombosis. Tissue factor (TF) exposure at…”
Get full text

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease by Festoff, Barry W, Sajja, Ravi K, van Dreden, Patrick, Cucullo, Luca

“…The blood-brain barrier (BBB) dysfunction represents an early feature of Alzheimer's disease (AD) that precedes the hallmarks of amyloid beta (amyloid β)…”
Get full text

Different sensitivity of von Clauss reagents for the diagnosis of dysfibrinogenemia by Vasse, Marc, Francois, Dominique, Van Dreden, Patrick, Mazancourt, Philippe

Get full text

PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells by Chivot, Justine, Ferrand, Nathalie, Fert, Aude, Van Dreden, Patrick, Morichon, Romain, Sabbah, Michèle

“…Poly (ADP-ribose) polymerase inhibitors (PARPi) are targeted therapies that inhibit PARP proteins which are involved in a variety of cell functions. PARPi may…”
Get full text

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells by Djedidi-Amrane, Rania, Rousseau, Aurélie, Larsen, Annette K, Elalamy, Ismail, Van Dreden, Patrick, Gerotziafas, Grigoris T

“…AbstractThe endothelium could be a potential target of cancer cell derived extracellular vesicles (CaCe-dEV). We investigated in vitro the effect of CaCe-dEV…”
Get full text

Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease by Lewis, Clayton S, Bari, Khurram, Xie, Changchun, Sherman, Kenneth E, Vasse, Marc, Van Dreden, Patrick, Bogdanov, Vladimir Y

“…Current quantitative approaches to assess chronic liver disease (CLD) severity have limitations. Further, portal vein thrombosis (PVT) pre-liver transplant…”
Get full text

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study by Fotiou, Despina, Sergentanis, Theodoros N., Papageorgiou, Loula, Stamatelopoulos, Kimon, Gavriatopoulou, Maria, Kastritis, Efstathios, Psaltopoulou, Theodora, Salta, Stella, Van Dreden, Patrick, Sangare, Rabiatou, Larsen, Annette K., Terpos, Evangelos, Elalamy, Ismail, Dimopoulos, Meletios A., Gerotziafas, Grigoris T.

“…Venous thromboembolism (VTE) is a common complication in newly diagnosed symptomatic multiple myeloma (NDMM) patients. We explored cellular and plasma…”
Get full text

Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia? by Rousseau, Aurélie, Favier, Rémi, Van Dreden, Patrick

“…Abstract Objective One of the most frequently proposed mechanisms for pre-eclampsia refers to uteroplacental thrombosis. However, the contribution of classical…”
Get full text

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability by Chaari, Mourad, Ayadi, Ines, Rousseau, Aurelie, Lefkou, Eleftheria, Van Dreden, Patrick, Sidibe, Fatoumata, Ketatni, Hela, Galea, Vassiliki, Khaterchi, Amir, Bouzguenda, Racem, Frikha, Mounir, Ghorbal, Lilia, Daoud, Jamel, Kallel, Choumous, Quinn, Martin, Gligorov, Joseph, Lotz, Jean Pierre, Hatmi, Mohamed, Elalamy, Ismail, Gerotziafas, Grigoris T

“…In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of…”
Get full text

Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia by Schneider, Pascale, Dreden, Patrick Van, Rousseau, Aurélie, Kassim, Yusra, Legrand, Elisabeth, Vannier, Jean‐Pierre, Vasse, Marc

“…Summary The use of l‐asparaginase (l‐ASP) in paediatric patients with acute lymphoblastic leukaemia (ALL) is associated with thrombotic complications. We…”
Get full text

Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome by Jutant, Etienne-Marie, Voiriot, Guillaume, Labbé, Vincent, Savale, Laurent, Mokrani, Hayat, Van Dreden, Patrick, Gerotziafas, Grigorios, Fartoukh, Muriel

“…Acute pulmonary hypertension (PH) may develop during sickle-cell acute chest syndrome (ACS), and is associated with an increased mortality. Its mechanisms…”
Get full text

Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7 by Gerotziafas, Grigoris T, Galea, Vassiliki, Mbemba, Elisabeth, Khaterchi, Amir, Sassi, Mouna, Baccouche, Hela, Prengel, Claudie, van Dreden, Patrick, Hatmi, Mohamed, Bernaudin, Jean François, Elalamy, Ismail

“…Abstract Cancer histology influences the risk of venous thromboembolism and tissue factor (TF) is the key molecule in cancer-induced hypercoagulability. We…”
Get full text

Prevalence of antiphospholipid antibodies in psychiatric patients users and non‐users of antipsychotics by Delluc, Aurélien, Rousseau, Aurélie, Le Galudec, Mickael, Canceil, Olivier, Woodhams, Barry, Etienne, Sylvie, Walter, Michel, Mottier, Dominique, Van Dreden, Patrick, Lacut, Karine

“…Summary Past reports have suggested that antiphospholipid (aPL) antibodies may emerge as a response to antipsychotics treatment, as a high prevalence of aPL…”
Get full text

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis by Martinelli, Nicola, Rigoni, Anna Maria, De Marchi, Sergio, Osti, Nicola, Donini, Martino, Montagnana, Martina, Castagna, Annalisa, Pattini, Patrizia, Udali, Silvia, De Franceschi, Lucia, Tinazzi, Elisa, Mazzi, Filippo, Moruzzi, Sara, Argentino, Giuseppe, Delfino, Lorenzo, Sartori, Giulia, Azzini, Anna Maria, Tacconelli, Evelina, Van Dreden, Patrick, Lippi, Giuseppe, Girelli, Domenico, Olivieri, Oliviero, Friso, Simonetta, Pizzolo, Francesca

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of coronavirus disease 2019 (COVID-19), in which coagulation abnormalities and…”
Get full text

The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1 by Sassi, Mouna, Chakroun, Taher, Mbemba, Elisabeth, Van Dreden, Patrick, Elalamy, Ismail, Larsen, Annette K, Gerotziafas, Grigoris T

“…A documented relationship between ovarian cancer and thrombosis does exist. Low-molecular-weight heparins (LMWHs) are cornerstone drugs in the primary…”
Get more information

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots by Salta, Stella, Papageorgiou, Loula, Larsen, Annette K., Van Dreden, Patrick, Soulier, Claire, Cokkinos, Dennis V., Elalamy, Ismail, Gerotziafas, Grigoris T.

“…Venous thromboembolism (VTE) is associated with significant morbidity and mortality. We investigated the impact of direct and AT‐dependent FXa or thrombin…”
Get full text

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study by Gerotziafas, Grigoris T, Van Dreden, Patrick, Mathieu d'Argent, Emmanuelle, Lefkou, Eleftheria, Grusse, Matthieu, Comtet, Marjorie, Sangare, Rabiatou, Ketatni, Hela, Larsen, Annette K, Elalamy, Ismail

“…Blood coagulation plays a crucial role in the blastocyst implantation process and its alteration may be related to in vitro fertilization (IVF) failure. We…”
Get full text

Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study by Gerotziafas, Grigorios T., Fotiou, Despina, Sergentanis, Theodoros N., Papageorgiou, Loula, Fareed, Jawed, Falanga, Anna, Sabbah, Michèle, Garderet, Laurent, Terpos, Evangelos, Elalamy, Ismail, Van Dreden, Patrick, Dimopoulos, Meletios A.

“…Biomarkers of hypercoagulability are potential candidates for the evaluation of risk for primary treatment resistance in patients with newly diagnosed multiple…”
Get full text